Folger Nolan Fleming Douglas Capital Management Inc. lessened its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 82,109 shares of the pharmacy operator’s stock after selling 733 shares during the quarter. Walgreens Boots Alliance makes up about 1.0% of Folger Nolan Fleming Douglas Capital Management Inc.’s investment portfolio, making the stock its 22nd largest position. Folger Nolan Fleming Douglas Capital Management Inc.’s holdings in Walgreens Boots Alliance were worth $6,430,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in WBA. Hudock Capital Group LLC raised its position in Walgreens Boots Alliance by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 6 shares during the last quarter. Reilly Financial Advisors LLC raised its position in Walgreens Boots Alliance by 7.9% in the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock valued at $107,000 after purchasing an additional 100 shares during the last quarter. Orrstown Financial Services Inc. raised its position in Walgreens Boots Alliance by 14.1% in the 2nd quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock valued at $135,000 after purchasing an additional 213 shares during the last quarter. Founders Capital Management bought a new position in Walgreens Boots Alliance in the 1st quarter valued at $161,000. Finally, Hanson McClain Inc. raised its position in Walgreens Boots Alliance by 4.6% in the 2nd quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock valued at $156,000 after purchasing an additional 87 shares during the last quarter. 63.58% of the stock is currently owned by institutional investors.

In other Walgreens Boots Alliance news, Director John Anthony Lederer bought 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, October 26th. The shares were purchased at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the acquisition, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the sale, the director now directly owns 16,415 shares in the company, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Corporate insiders own 13.50% of the company’s stock.

Several equities analysts have issued reports on WBA shares. Morgan Stanley downgraded Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating and cut their price objective for the company from $95.00 to $85.00 in a research report on Friday, October 6th. Robert W. Baird reiterated an “outperform” rating and issued a $80.00 price objective (down previously from $90.00) on shares of Walgreens Boots Alliance in a research report on Thursday, October 19th. They noted that the move was a valuation call. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, August 30th. Zacks Investment Research downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday, October 17th. Finally, Needham & Company LLC restated a “buy” rating and set a $94.00 target price on shares of Walgreens Boots Alliance in a research report on Sunday, September 10th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company’s stock. Walgreens Boots Alliance has an average rating of “Buy” and an average price target of $87.63.

COPYRIGHT VIOLATION NOTICE: “Folger Nolan Fleming Douglas Capital Management Inc. Sells 733 Shares of Walgreens Boots Alliance, Inc. (WBA)” was first posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/folger-nolan-fleming-douglas-capital-management-inc-sells-733-shares-of-walgreens-boots-alliance-inc-wba/1699405.html.

Walgreens Boots Alliance, Inc. (WBA) opened at $70.99 on Monday. The firm has a market capitalization of $71,667.88, a P/E ratio of 13.92, a PEG ratio of 1.26 and a beta of 1.20. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07. Walgreens Boots Alliance, Inc. has a 52 week low of $63.82 and a 52 week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.21 by $0.10. The business had revenue of $30.15 billion for the quarter, compared to the consensus estimate of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The firm’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.07 earnings per share. research analysts expect that Walgreens Boots Alliance, Inc. will post 5.55 EPS for the current year.

Walgreens Boots Alliance announced that its board has authorized a stock buyback plan on Wednesday, October 25th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to reacquire shares of its stock through open market purchases. Shares buyback plans are generally an indication that the company’s leadership believes its stock is undervalued.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date is Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio is currently 42.33%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.